Paragonix Technologies Raises $24M in Series B
Summary
CAMBRIDGE, MA, Paragonix Technologies, a leading organ transplant company, announced that it has secured $24M in Series B funding, Paragonix Technologies, a leading organ transplant company,announced that it has secured $24M in Series B funding, led by Signet Healthcare Partners. This growth investment will bolster Paragonix Technologies commercial footprint, including its ongoing extension of clinical service offerings and inventory expansion, and will enable the Company to further advance transplant innovations. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
Funding
Amount
$24.0M
Total raised
Date
March 27, 2023
Announcement date
Investors
Video Island
Lead investors
Company
http://www.paragonixtechnologies.com
Funded company
Classifications
industries
No industries detected
applications
Business Intelligence
AskAI Classifications
Labels
No AI classifications detected
